Neurofilament as a potential biomarker for spinal muscular atrophy
Basil T Darras, Thomas O Crawford, Richard S Finkel, Eugenio Mercuri, Darryl C De Vivo, Maryam Oskoui, Eduardo F Tizzano, Monique M Ryan, Francesco Muntoni, Guolin Zhao, John Staropoli, Alexander McCampbell, Marco Petrillo, Christopher Stebbins, Stephanie Fradette, Wildon Farwell, Charlotte J Sumner
Annals of Clinical and Translational Neurology | WILEY | Published : 2019
The authors would like to thank the children who participated in these studies and their parents/guardians, the staff at Boston Children's Hospital for their collaboration in providing blood samples from children without SMA, and all investigators and staff involved in the ENDEAR trial. F.M. is supported by the National Institute for Health Research (NIHR) Great Ormond Street Hospital Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health.